Frequency, impact and a preclinical study of novel ERBB gene family mutations in HER2-positive breast cancer

Therapeutic Advances in Medical Oncology
Naomi ElsterAlex J Eustace

Abstract

Somatic mutations in the ERBB genes (epidermal growth factor receptor: EGFR, ERBB2, ERBB3, ERBB4) promote oncogenesis and lapatinib resistance in metastatic HER2+ (human epidermal growth factor-like receptor 2) breast cancer in vitro. Our study aimed to determine the frequency of mutations in four genes: EGFR, ERBB2, ERBB3 and ERBB4 and to investigate whether these mutations affect cellular behaviour and therapy response in vitro and outcomes after adjuvant trastuzumab-based therapy in clinical samples. We performed Agena MassArray analysis of 227 HER2+ breast cancer samples to identify the type and frequency of ERBB family mutations. Of these, two mutations, the somatic mutations ERBB4-V721I and ERBB4-S303F, were stably transfected into HCC1954 (PIK3CA mutant), HCC1569 (PIK3CA wildtype) and BT474 (PIK3CA mutant, ER positive) HER2+ breast cancer cell lines for functional in vitro experiments. A total of 12 somatic, likely deleterious mutations in the kinase and furin-like domains of the ERBB genes (3 EGFR, 1 ERBB2, 3 ERBB3, 5 ERBB4) were identified in 7% of HER2+ breast cancers, with ERBB4 the most frequently mutated gene. The ERBB4-V721I kinase domain mutation significantly increased 3D-colony formation in 3/3 cell lines, wher...Continue Reading

References

Jun 26, 2003·Nucleic Acids Research·Pauline C Ng, Steven Henikoff
Oct 6, 2005·Proceedings of the National Academy of Sciences of the United States of America·Samuel BouyainDaniel J Leahy
Oct 21, 2005·The New England Journal of Medicine·Martine J Piccart-GebhartUNKNOWN Herceptin Adjuvant (HERA) Trial Study Team
Apr 17, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Torsten TroweTimothy S Heuer
Oct 28, 2008·Experimental Cell Research·Graham Carpenter, Hong-Jun Liao
Nov 18, 2008·Experimental Cell Research·Carl P BlobelMatthew Freeman
Dec 23, 2008·The Journal of Biological Chemistry·Denis TvorogovKlaus Elenius
Nov 4, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Ana M Gonzalez-AnguloGabriel N Hortobagyi
May 27, 2010·Molecular Cancer Therapeutics·Neil A O'BrienDennis J Slamon
Aug 22, 2012·Proceedings of the National Academy of Sciences of the United States of America·Heidi GreulichMatthew Meyerson
Oct 27, 2012·Breast Cancer : the Journal of the Japanese Breast Cancer Society·Saori FujiwaraHirotaka Iwase
Dec 12, 2012·Cancer Discovery·Ron BoseMatthew J Ellis
Jan 8, 2013·Annals of Oncology : Official Journal of the European Society for Medical Oncology·D TougeronL Karayan-Tapon
May 18, 2013·Cancer Cell·Bijay S JaiswalSomasekar Seshagiri
Aug 21, 2013·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Brent N RexerCarlos L Arteaga
Dec 30, 2014·Breast Cancer Research and Treatment·N ElsterB T Hennessy
Sep 4, 2015·Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals·Gloria Yang-KolodjiDebu Tripathy
May 3, 2016·Cell Systems·Martin L MillerChris Sander

❮ Previous
Next ❯

Methods Mentioned

BETA
genotyping
protein array
transfection
immunoprecipitation

Software Mentioned

CalcuSyn
AVSIFT
Graphpad Prism
Mutation Assessor

Related Concepts

Related Feeds

Breast Invasive Carcinoma (Keystone)

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Breast Cancer: Risk Factors

Breast cancer is a multifactorial disease that is influenced by both environmental and genetic factors. Discover the latest research on the environmental and genetic risk factors for breast cancer here.

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.

Breast Invasive Carcinoma

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.